Monroe Bank & Trust’s Allergan plc AGN Stock Holding History

Monroe Bank & Trust’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-47	Closed	-$13K	–	331
2016 Q1	$13K	Buy	+47	New	+$13.5K	﹤0.01%	256

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Monroe Bank & Trust's AGN Position: Q2 2016 in Review

Monroe Bank & Trust sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 47 shares — an estimated $13K sold.

Monroe Bank & Trust first reported a position in AGN in Q1 2016 and held it in 1 quarter. The position peaked at $13K in Q1 2016. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

Monroe Bank & Trust reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
Monroe Bank & Trust sold 47 Allergan plc shares in Q2 2016, an estimated $13K.
Monroe Bank & Trust first reported a position in Allergan plc in Q1 2016 and held it in 1 quarter.
Monroe Bank & Trust's Allergan plc position peaked at $13K in Q1 2016.
1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Monroe Bank & Trust's 13F filing for Q2 2016, filed 10 Aug 2016.